Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol with Neoadjuvant Chemotherapy in Breast Cancer
NCT01847001Phase 2Completed
- Sponsor
- Columbia University
- Start
- Oct 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propranolol in breast cancer, sponsored by Columbia University. Primary endpoints: Mean Adherence to Propranolol at 6 months and Total Number of Participants Who Reached The Target Propranolol Dosing at 6 months. Started Oct 2012; status: completed.
02
Drugs
propranolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01847001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847001.